The French parts maker cut 2026 targets and plans 770 European job cuts, and the damage is spreading across the…
What’s open for comment before October 26?
October 7, 2026 Bonus Content: Drones Are Replacing Medical Couriers. Cleveland Clinic Made It Permanent. A note from our friends…
Informa Just Shed Its Publishing Past. What’s Left Matters.
When a private equity firm sells a business it bought for £600 million and collects £2.24 billion in return, most…
HCA’s AI Scheduler Is Saving Money and Angering Nurses
The Palantir-powered Timpani rollout spotlights a key question: whose judgment the algorithm actually replaces.
Nebius Surged 9% on a Deal With No Price Tag. Options Say Sell the Pop.
After a 197x earnings multiple and a COO cashing out, the more interesting trade on NBIS is not the one…
Your Bank Is Getting Cut Out of the Cash Business
Corporate treasurers are building short-term credit portfolios, and the fee income banks counted on is going with them.
Genmab Halved Progression Risk Without a Sales Force
Diffuse large B-cell lymphoma is the most common aggressive subtype of non-Hodgkin lymphoma, and for decades its frontline treatment has…
Genmab Halved Progression Risk Without a Sales Force
Phase 3 EPCORE DLBCL-2 shows how partnerships can compound value
America’s Drone Demand Is Growing. This Nasdaq’s Opportunity May Be Even Bigger.
October 6, 2026 Bonus Content: The €5 Billion Elevator Business Every Industrial Giant Wants A note from our friends at…
SMRs Just Got a Construction Permit. An Operating License Is Still Years Away.
The NRC cleared TVA's Clinch River reactor on Sept. 29. Here is what still stands between that milestone and actual…